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PURPOSE. Resveratrol is a red wine polyphenol that causes vasorelaxation, which could be of
interest in the treatment or prevention of eye diseases with an impaired blood flow. In this
study, the vasorelaxant capacity of resveratrol (cis and trans) on bovine retinal arteries, its
vasorelaxing mechanism, and its influence on the relaxation induced by the retinal relaxing
factor (RRF) were examined.
METHODS. Isolated bovine retinal arteries were mounted into wire myographs for isometric
tension measurements. Concentration-response curves of cis- and trans-resveratrol and
concentration-response curves of resveratrol in the absence or presence of the endothelium
or different inhibitors were constructed. Relaxations elicited by the RRF with and without
resveratrol incubation were also compared.
RESULTS. Both resveratrol isomers caused a similar strong concentration-dependent relaxation.
Removal of the endothelium or blocking endothelium-dependent pathways did not change
the relaxation. Also, Kþ channel blockers did not reduce the relaxation, except the 120 mM
Kþ Krebs Ringer bicarbonate solution. Phorbol 12-myristate 13-acetate and phorbol 12,13-
dibutyrate blocked the relaxation partially and so did the inhibition of heme oxygenase-1.
Blocking adenylyl cyclase, AMP-activated protein kinase, estrogen receptors, sirtuin 1, or
sarco/endoplasmic reticulum Ca2þ ATPase did not have an effect. The relaxation caused by
the RRF was not altered by resveratrol incubation.
CONCLUSIONS. Cis- and trans-resveratrol relax bovine retinal arteries similarly and concentration
dependently. The main relaxation mechanism remains unclear, but Kþ channels, carbon
monoxide, and the myosin phosphatase pathway may be involved. Resveratrol does not have
an influence on the RRF.
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In an era with huge interest in healthy food and nutraceut-icals, much attention is given to resveratrol, a polyphenolic
compound present in the skin of grapes and thus in red
wine.1–3 Resveratrol is also found in other foods, such as
cranberries and peanuts. However, it is best absorbed from the
wine matrix. The interest in resveratrol has exploded since
resveratrol was advanced as being responsible for the
cardiovascular benefit of moderate red wine consumption.2
This hypothesis originates from the so-called French paradox,
the lower incidence of cardiovascular diseases in the French
population despite their higher intake of dietary saturated
fat.1,4 The potential beneficial effects of resveratrol are
explained by many studies showing that resveratrol has
vasorelaxant, antioxidant, antiapoptotic, antitumorigenic, anti-
angiogenic, and anti-inflammatory properties.5
These properties are also of interest for diseases of the eye.
Many studies have already focused on the potential effect of
resveratrol on eye diseases. It has been proven that resveratrol
causes a decrease in the expression of glaucoma markers as a
result of its antioxidant, anti-inflammatory, and antiapoptotic
properties.6 Resveratrol also reduces diabetic retinopathy7 and
apoptosis and/or oxidative stress in models of (diabetic)
cataract.8–10 Furthermore, resveratrol protects retinal pigment
epithelial cells against oxidative stress, which is involved in the
pathogenesis of age-related macular degeneration.11 Resveratrol
also inhibits the tumor growth of uveal melanoma and
retinoblastoma and the neovascularization in animal models
of retinopathy of prematurity and macula telangiectasia.12–15
Resveratrol is also well known for its vasorelaxing influence.
However, studies on its effect on retinal circulation are scarce
despite the fact that the vasorelaxant activity of resveratrol
would be beneficial to treat or prevent eye diseases associated
with an impaired blood flow, such as glaucoma, age-related
macular degeneration, and diabetic retinopathy.5 As yet only
one study has reported that resveratrol relaxes retinal arteries;
porcine retinal arterioles are relaxed by resveratrol, and this
occurs through both an endothelium-dependent (nitric oxide
[NO]-mediated) and endothelium-independent (large-conduc-
tance Ca2þ-activated Kþ channels-mediated) mechanism.16
The aim of the present study was to investigate whether
resveratrol also relaxes retinal arteries from another species,
namely bovine retinal arteries; potential differences between
cis- and trans-resveratrol; the potential mechanisms involved in
the vasorelaxing action of resveratrol; and a potential influence
of resveratrol on the continuously released retinal relaxing
factor (RRF).17–19
METHODS
Tissue Preparation
Bovine eyes were obtained from the local slaughterhouse and
were transported and stored in cold Krebs Ringer bicarbon-
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ate (KRB) solution. Extraocular muscles and connective
tissue were cut off the eye. The eyecup was then cut open
and the anterior segment and the vitreous were removed.
Under a dissection microscope, the part of the retinal artery
between the optic disc and the first branching of the artery
was gently detached with its surrounding retinal tissue from
the choroid.
The retinal arterial segments were mounted into wire
myographs (constructed by the technical department of the
research unit) for isometric tension measurements containing
10 mL KRB solution (378C, pH 7.4, and bubbled with 95% O2–
5% CO2). Two stainless steel wires of 40 lm diameter were
guided through the lumen of the vessel. One wire was
connected to a force-displacement transducer and the other
to a micrometer. Before guiding the wires through the lumen of
the artery, the adhering retinal tissue was carefully removed.
The femoral arteries were dissected from Swiss mice (8–12
weeks, from Janvier, Saint-Berthevin, France) and cleaned from
its surrounding tissue after guiding the first wire through the
lumen of the artery.
The arterial segments were allowed to equilibrate for 30
minutes in the KRB solution before their normalization. During
the normalization process, the passive wall tension–internal
circumference characteristics of the vessels were determined.
The internal circumference of the vessels was then set to 90%
of the internal circumference of the vessels at a transmural
pressure of 100 mmHg.
At the start of each experiment, the arteries were three times
contracted by adding 120 mM Kþ KRB solution and 30 lM
prostaglandin F2a (PGF2a) to the organ bath. Next, 0.1 mM
acetylcholine (Ach) was added to a retinal artery contracted with
30 lM PGF2a to test the functionality of the endothelium.17,19
Experimental Protocols
To test the potential difference in relaxation between cis- and
trans-resveratrol, concentration-response curves of cis- and
trans-resveratrol (1–100 lM) were performed on the same
PGF2a-contracted bovine retinal arteries. To investigate the
relaxation mechanism, the concentration-response curves of
resveratrol were performed on arteries with or without
endothelium or in the presence or absence of blockers of
certain pathways. The influence of resveratrol on the RRF
response was tested by comparing the relaxing effect, elicited
by placing retinal tissue on the precontracted artery with and
without incubation of the retina and artery with resveratrol
and performed on the same artery with the same retina.
Because placing a piece of bovine retina on bovine retinal
arteries caused 100% relaxation and so a possible enlargement
of the relaxing effect could not be detected, mouse retinas and
mice femoral arteries were used instead, as previously
described.20
Drugs and Chemicals
The KRB solution contained the following components (mM):
NaCl 135, KCl 5, NaHCO3 20, glucose 10, CaCl2 2.5, MgSO4
1.3, KH2PO4 1.2, and EDTA 0.026 in H2O. The 120 mM K
þ and
30 mM KþKRB solutions were made by equimolar replacement
of NaCl by KCl. (Trans-) resveratrol, Ach, tetraethylammonium
(TEA), Nx-nitro-L-arginine methyl ester hydrochloride (L-
NAME), indomethacin, 4-aminopyridine (4-AP), glibenclamide,
1H-[1,2, 4]oxadiazolo[4,3,-a]quinoxalin-1-one (ODQ), phorbol
12-myristate 13-acetate (PMA), compound C, zinc protopor-
phyrin IX (ZnPP), fulvestrant (ICI 182780), cyclopiazonic acid
(CPA), niacinamide, PD98059, SQ 22,536, and EX-527 were
obtained from Sigma-Aldrich (St. Louis, MO, USA), PGF2a from
Zoetis (Florham Park, NJ, USA), phorbol 12,13-dibyturate
(PDBu) from Axon MedChem (Groningen, The Netherlands),
cis-resveratrol from Cayman (Ann Harbor, MI, USA) and
papaverine from Sterop (Brussels, Belgium). All stock solutions
were made in DMSO, except those of PGF2a, Ach, TEA, 4-AP, L-
NAME, niacinamide, and papaverine, which were made in
water, indomethacin was made in ethanol, and ZnPP was made
in 0.1M NaOH.
Data Analysis
The data were computed as mean 6 SEM and evaluated
statistically using a Wilcoxon test. Two groups of data were
considered significantly different if P < 0.05. Relaxations are
expressed in percent decrease of the preexisting tone elicited
by PGF2a (n¼ number of preparations tested from all different
animals).
RESULTS
Effect of Trans- and Cis-Resveratrol
Resveratrol relaxed bovine retinal arteries clearly concentra-
tion dependently (Fig. 1). A rapid and almost complete
relaxation was reached at the concentration of 0.1 mM
(trans-resveratrol: 102.27% 6 7.09; cis-resveratrol: 90.44% 6
8.08). The EC50 of trans- and cis-resveratrol was, respectively,
31.67 lM 6 9.64 and 39.54 lM 6 8.19 (Fig. 2). Because there
was no significant difference detected, further experiments
were performed using only trans-resveratrol.
FIGURE 1. Original tracing showing the relaxation curve of (trans-)
resveratrol (Resv) on 30 lM PGF2a contracted bovine retinal arteries.
FIGURE 2. Percentage relaxation of bovine retinal arteries caused by
trans- and cis-resveratrol (1–100 lM); n¼ 4. *P < 0.05.
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Role of Endothelium and NO
Removal of the endothelium, performed by rubbing a hair
through the lumen and considered successful if 0.1 mM
acetylcholine did not induce a relaxation, did not reduce the
relaxation (Fig. 3A). Also, the incubation with the NO-synthase
inhibitor L-NAME (0.1 mM, 10 minutes), the soluble guanylyl
cyclase (sGC) inhibitor ODQ (10 lM, 20 minutes), the
cyclooxygenase (COX) inhibitor indomethacin (10 lM, 20
minutes), or the mitogen-activated protein kinases / extracel-
lular signal-regulated kinases (MAPK/ERK) inhibitor PD98059
(10 lM, 20 minutes) did not change the relaxation (Fig. 3B–E).
Role of Kþ Channels
The 120 mM Kþ KRB solution (20 minutes) inhibited the
resveratrol relaxation slightly. However, a significant difference
was detected at the concentration of 0.1 mM resveratrol
(97.02% 6 3.08 vs. 82.88% 6 4.74) (Fig. 4A). The nonselective
Kþ channel blocker TEA (10 mM, 20 minutes), the voltage-
gated Kþ channel blocker 4-AP (2 mM, 20 minutes), and the
ATP-sensitive Kþ channel blocker glibenclamide (10 lM, 20
minutes) did not reduce the relaxation (Fig. 4B–D). The
relaxation in the presence of glibenclamide was even
somewhat increased, probably a result of the impaired
precontractile tone.
Role of Protein Kinase C
Both protein kinase C (PKC) activators PMA (10 lM, 20
minutes) and PDBu (1 lM, 20 minutes) decreased the
relaxation caused by resveratrol (Fig. 5A, 5B). The presence
of PMA caused a small but significant increased relaxation in
response to 3 lM of resveratrol, but a large significant
decreased relaxation in response to 100 lM of resveratrol
(89.51% 6 5.40 vs. 60.45% 6 5.03). PDBu significantly
reduced the relaxation at resveratrol concentrations of 1 lM,
30 lM, and 100 lM (81.31% 6 7.16 vs. 48.23% 6 7.21 at 100
lM resveratrol).
Role of Other Mediators
The adenylyl cyclase (AC) blocker SQ 22,536 (0.1 mM, 20
minutes) and the AMP-activated protein kinase (AMPK) blocker
compound C (10 lM, 20 minutes) did not reduce the
resveratrol-induced relaxation (Fig. 6A, 6B). In addition, neither
did the estrogen receptor blocker fulvestrant (0.1 mM, 20
minutes), nor the sarco/endoplasmic reticulum Ca2þ ATPase
(SERCA) blocker CPA (10 lM, 20 minutes), nor the sirtuin 1
blockers EX-527 (5 lM, 15 minutes) and niacinamide (10 mM,
20 minutes) (results not shown) reduce the resveratrol
relaxation (Fig. 6C–E). The incubation with fulvestrant reduced
the contractile tone, explaining the larger relaxation percent-
ages. ZnPP (10 lM, 60 minutes), a blocker of heme oxygenase-
FIGURE 3. Percentage relaxation of bovine retinal arteries caused by resveratrol (1–100 lM) in the presence or absence of the endothelium (A), L-
NAME (0.1 mM) (B), indomethacin (10 lM) (C), ODQ (10 lM) (D), PD98059 (10 lM) (E); n¼ 4. *P < 0.05.
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1 (HO-1), did cause a significant reduction at resveratrol
concentrations of 3 lM, 10 lM, and 100 lM (95.50% 6 1.22 vs.
78.37% 6 8.48 at 100 lM resveratrol) (Fig. 6F).
Influence of Resveratrol on the RRF
The relaxation of mice femoral arteries caused by placing a
mouse retina on top of the femoral artery (as previously
described20) was similar before and after incubating the retina
and femoral artery with resveratrol (0.1 mM, 15 minutes)
(24.91% 6 2.35 and 24.40% 6 4.91, respectively) (Fig. 7).
DISCUSSION
Our study demonstrates for the first time that resveratrol has a
very prominent relaxing influence on bovine retinal arteries.
Relaxation starts at a concentration of 3 lM and is almost
complete at a concentration of 0.1 mM, similar to the
relaxation on porcine retinal arterioles.16 Retinal arteries have
approximately the same sensitivity to resveratrol as porcine
and sheep coronary arteries and rat aortas because their EC50 is
similar.21–23 The EC50 turns out to be higher for human internal
mammary arteries and lower for rat abdominal aortas and rat
mesenteric arteries.24–26
Resveratrol exists as both cis- and trans-isomers. Cis-
resveratrol is found only in small amounts in grapes because
trans-resveratrol is the more stable natural form. However,
trans-resveratrol can be transformed into the cis-isomer by
ultraviolet irradiation or yeast isomerases during fermentation,
with the result that cis-resveratrol is present in wine at variable
concentrations.5,27–29 Differences in effectivity of the isomers
have been reported. Several studies provided evidence that the
antioxidant capacity of trans-resveratrol is the strongest,
whereas other studies showed a similar effect.27,30,31 Further-
more, trans-resveratrol has been shown to be a stronger
inhibitor of platelet aggregation, angiogenesis, and tumor
growth in vivo than cis-resveratrol, and only trans-resveratrol
is able to inhibit vascular inflammation.32–34 The present study
shows that both isomers have a similar vasorelaxing effect, at
least in bovine retinal arteries. To the best of our knowledge,
isomer sensitivity has not yet been studied on other blood
vessels.
Many studies have shown that the vasorelaxing effect of
resveratrol depends at least partially on the presence of
endothelium and the formation of NO.16,21,25 On porcine
retinal arteries, the relaxation of resveratrol is partially
mediated by NO released from the endothelium.16 However,
our study provides no evidence for that in bovine retinal
arteries. Removal of the endothelium, blocking NO-synthase
with L-NAME or blocking COX with indomethacin, does not
FIGURE 4. Percentage relaxation of bovine retinal arteries caused by resveratrol (1–100 lM) in the absence or presence of 120 mM Kþ KRB solution
(A), TEA (10 mM) (B), 4-AP (2 mM) (C), glibenclamide (10 lM) (D); n¼ 4 to 6. *P < 0.05.
FIGURE 5. Percentage relaxation of bovine retinal arteries caused by
resveratrol (1–100 lM) in the absence or presence of PMA (10 lM) (A),
PDBu (1 lM) (B); n ¼ 5 to 6. *P < 0.05.
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alter the relaxation in response to resveratrol. However, it
should also be noted that on other blood vessels L-NAME failed
to block the resveratrol relaxation35,36 and COX has not yet
been reported to be involved in the relaxation caused by
resveratrol.16,21,25,35,37 It has also been revealed that the
release of NO in porcine retinal arteries is activated by the
MAPK/ERK pathway and that NO activates then sGC.16 Also,
these mediators do not seem to be involved in the relaxation
on bovine retinal arteries.
The endothelium-independent pathway of resveratrol on
porcine retinal arterioles is mediated by large-conductance
Ca2þ-activated Kþ channels, the nonselective Kþ channel
blocker TEA blocked the relaxation significantly.16 This is not
seen in bovine retinal arteries. Incubation with 120 mM Kþ
KRB solution reduced the relaxation caused by 0.1 mM
resveratrol minimally, indicating only a small involvement of
Kþ channels. In other tissues, resveratrol relaxations could be
partially blocked by glibenclamide or 4-AP, even when TEA
failed to block the relaxation.26,38 However, this was not the
case with bovine retinal arteries. All used Kþ blockers failed to
block the relaxation of resveratrol. This is in line with what has
been reported on mouse corpus cavernosum.35
Resveratrol has also been reported to form cGMP through
particulate or membrane-bound guanylyl cyclase (pGC) and
not through sGC.22 Because pGC is blocked by PKC, the PKC
activators PMA and PDBu were used to inhibit pGC.39 Both
reduced the relaxation of resveratrol significantly, with PDBu
having the strongest effect. From this it could be concluded
that resveratrol induces relaxation partially via pGC. However,
earlier research on bovine retinal arteries showed very little
relaxation in response to cGMP.40 Therefore, it is unlikely that
pGC plays a substantial role in the strong resveratrol relaxation.
It should be mentioned that the activation of PKC also has
other effects besides blocking pGC, such as inactivating
myosin phosphatase (as does Rho-kinase), which then can no
longer dephosphorylate the light chain of myosin to induce
relaxation.41 Therefore, an interaction of resveratrol with the
myosin phosphatase pathway could be involved in the
relaxation effect of resveratrol. Rho-kinase inhibition has
previously been reported to make a major contribution to
the resveratrol-induced vasorelaxation.42 We tried to test this
influence by blocking Rho-kinase with Y-27632 dihydrochlo-
FIGURE 6. Percentage relaxation of bovine retinal arteries caused by resveratrol (1–100 lM) in the absence or presence of SQ 22,536 (0.1 mM) (A),
compound C (10 lM) (B), fulvestrant (0.1 mM) (C), CPA (10 lM) (D), EX-527 (5 lM) (E), ZnPP (10 lM) (F); n¼ 4 to 6; *P < 0.05.
FIGURE 7. Percentage relaxation of mice femoral arteries caused by
the RRF in the absence or presence of resveratrol (0.1 mM); n¼4. *P <
0.05.
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ride, but the incubation caused loss of contractile tone, which
could be explained by the fact that Y-27632 dihydrochoride is a
strong dilator of PGF2a-contracted retinal arteries.
43 To be sure
that the inhibition of the resveratrol relaxation by PMA or
PDBu is not aspecific, experiments were carried out with
papaverine, a strong dilator of bovine retinal arteries.40
Relaxations in response to papaverine were not affected by
PDBu (Fig. 8), proving that PDBu blocks the resveratrol
relaxation in a specific way.
The potential involvement of cAMP was also verified,
although resveratrol activates rather cGMP than cAMP.22
Indeed, the resveratrol relaxation was not changed by
inhibiting AC with SQ 22,536. Furthermore, it has been
described that resveratrol interacts with SERCA, AMPK, sirtuin
1, and the estrogen receptor,44–48 but none of these seem to be
involved in the relaxation as respectively, CPA, compound C,
EX-527, niacinamide, and fulvestrant did not alter the
resveratrol relaxation. It has been described that resveratrol
activates HO-1,49 which can be confirmed because the
relaxation was a little, but significantly, reduced by ZnPP, a
HO-1 blocker. HO-1 catalyzes the degradation of heme, which
results in the production of CO.50
So the relaxation mechanisms of resveratrol on porcine
retinal arterioles seem to differ from those on bovine retinal
arteries.16 However, it should be mentioned that besides
species and caliber differences, the experimental setup was
also different, which might have influenced the results. In our
study, the arteries were mounted into a wire myograph for
isometric force measurements, in the other study the arteries
were cannulated for isobaric diameter measurements. The
arteries in the wire mygraph show only a passive tension, so a
vasoconstrictor has to be added first to see a vasorelaxing
effect. The cannulated arteries in the pressure myograph have
already a certain tone, probably a result of myogenic
autoregulatory mechanisms,51 so a preconstrictor is not
needed to detect vasorelaxing effects.
It has been shown that the presence of retinal tissue
influences the tone of retinal arteries by releasing a relaxing
factor (so called retinal relaxing factor, RRF).17,18 The identity
of the RRF is still a matter of debate, but Takir et al. investigated
the vasorelaxing mechanism of the RRF. An induction of
relaxation by activating inward rectifier Kþ channels and an
inhibition of contraction by inhibiting the Ca2þ sensitization
pathway probably via the Rho-kinase pathway was suggested.43
Changes in the RRF pathway could affect the retinal blood
flow. Therefore, in bioassay experiments we also investigated
whether resveratrol influences the relaxing effect of RRF
elicited by placing mouse retinal tissue on a precontracted
mouse femoral artery. However, the RRF-induced relaxing
effect was not influenced by incubation with resveratrol.
In conclusion, trans- and cis-resveratrol relax bovine retinal
arteries similarly and clearly concentration dependently. The
relaxation mechanism of resveratrol on these arteries is still
unclear and differs from that on porcine retinal arteries. There
might be a small involvement of Kþ channels, CO, and the
myosin phosphatase pathway. Further mechanisms explaining
the complete relaxation caused by resveratrol remain to be
discovered. In addition, resveratrol does not seem to influence
the relaxing influence of the RRF.
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